IBDEI1C4 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23917,1,2,0)
 ;;=2^753.10
 ;;^UTILITY(U,$J,358.3,23917,1,5,0)
 ;;=5^Renal Cysts
 ;;^UTILITY(U,$J,358.3,23917,2)
 ;;=^104720
 ;;^UTILITY(U,$J,358.3,23918,0)
 ;;=753.16^^153^1524^29
 ;;^UTILITY(U,$J,358.3,23918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23918,1,2,0)
 ;;=2^753.16
 ;;^UTILITY(U,$J,358.3,23918,1,5,0)
 ;;=5^Medullary Cystic Kidney
 ;;^UTILITY(U,$J,358.3,23918,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,23919,0)
 ;;=590.00^^153^1524^14
 ;;^UTILITY(U,$J,358.3,23919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23919,1,2,0)
 ;;=2^590.00
 ;;^UTILITY(U,$J,358.3,23919,1,5,0)
 ;;=5^Chr Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,23919,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,23920,0)
 ;;=590.01^^153^1524^13
 ;;^UTILITY(U,$J,358.3,23920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23920,1,2,0)
 ;;=2^590.01
 ;;^UTILITY(U,$J,358.3,23920,1,5,0)
 ;;=5^Chr Pyeloneph w/ Les Ren Med Necrosis
 ;;^UTILITY(U,$J,358.3,23920,2)
 ;;=^270368
 ;;^UTILITY(U,$J,358.3,23921,0)
 ;;=590.10^^153^1524^2
 ;;^UTILITY(U,$J,358.3,23921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23921,1,2,0)
 ;;=2^590.10
 ;;^UTILITY(U,$J,358.3,23921,1,5,0)
 ;;=5^Acute Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,23921,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,23922,0)
 ;;=590.11^^153^1524^1
 ;;^UTILITY(U,$J,358.3,23922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23922,1,2,0)
 ;;=2^590.11
 ;;^UTILITY(U,$J,358.3,23922,1,5,0)
 ;;=5^AC Pyeloneph w/ Les Ren Med Necrosis
 ;;^UTILITY(U,$J,358.3,23922,2)
 ;;=^270370
 ;;^UTILITY(U,$J,358.3,23923,0)
 ;;=590.2^^153^1524^36
 ;;^UTILITY(U,$J,358.3,23923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23923,1,2,0)
 ;;=2^590.2
 ;;^UTILITY(U,$J,358.3,23923,1,5,0)
 ;;=5^Renal & Perinephric Abscess
 ;;^UTILITY(U,$J,358.3,23923,2)
 ;;=^270371
 ;;^UTILITY(U,$J,358.3,23924,0)
 ;;=590.3^^153^1524^35
 ;;^UTILITY(U,$J,358.3,23924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23924,1,2,0)
 ;;=2^590.3
 ;;^UTILITY(U,$J,358.3,23924,1,5,0)
 ;;=5^Pyeloureteritis Cystica
 ;;^UTILITY(U,$J,358.3,23924,2)
 ;;=^270372
 ;;^UTILITY(U,$J,358.3,23925,0)
 ;;=590.80^^153^1524^34
 ;;^UTILITY(U,$J,358.3,23925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23925,1,2,0)
 ;;=2^590.80
 ;;^UTILITY(U,$J,358.3,23925,1,5,0)
 ;;=5^Pyelonephritis,Unspec
 ;;^UTILITY(U,$J,358.3,23925,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,23926,0)
 ;;=590.81^^153^1524^33
 ;;^UTILITY(U,$J,358.3,23926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23926,1,2,0)
 ;;=2^590.81
 ;;^UTILITY(U,$J,358.3,23926,1,5,0)
 ;;=5^Pyelitis/Pyeloneph in Oth Diseases
 ;;^UTILITY(U,$J,358.3,23926,2)
 ;;=^270375
 ;;^UTILITY(U,$J,358.3,23927,0)
 ;;=189.0^^153^1524^25
 ;;^UTILITY(U,$J,358.3,23927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23927,1,2,0)
 ;;=2^189.0
 ;;^UTILITY(U,$J,358.3,23927,1,5,0)
 ;;=5^Malig Neo Kidney,Primary
 ;;^UTILITY(U,$J,358.3,23927,2)
 ;;=^73523
 ;;^UTILITY(U,$J,358.3,23928,0)
 ;;=189.1^^153^1524^27
 ;;^UTILITY(U,$J,358.3,23928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23928,1,2,0)
 ;;=2^189.1
 ;;^UTILITY(U,$J,358.3,23928,1,5,0)
 ;;=5^Malig Neo Renal Pelvis
 ;;^UTILITY(U,$J,358.3,23928,2)
 ;;=^267264
 ;;^UTILITY(U,$J,358.3,23929,0)
 ;;=189.2^^153^1524^28
 ;;^UTILITY(U,$J,358.3,23929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23929,1,2,0)
 ;;=2^189.2
 ;;^UTILITY(U,$J,358.3,23929,1,5,0)
 ;;=5^Malig Neo Ureter
 ;;^UTILITY(U,$J,358.3,23929,2)
 ;;=^267265
 ;;^UTILITY(U,$J,358.3,23930,0)
 ;;=198.0^^153^1524^26
 ;;^UTILITY(U,$J,358.3,23930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23930,1,2,0)
 ;;=2^198.0
